Skip to content
  • Tuesday, 27 October 2026
  • 10:34 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Gilead Sciences and Vir Biotechnology Expand Strategic Oncology Partnership in Multi-Billion-Dollar T-Cell Engager Deal for Solid Tumors
Pharmaceutical R&D

Gilead Sciences and Vir Biotechnology Expand Strategic Oncology Partnership in Multi-Billion-Dollar T-Cell Engager Deal for Solid Tumors

Teuku Ryan Oct 16, 2026 0

Gilead Sciences and Vir Biotechnology have significantly expanded their strategic research and development alliance through a newly finalized licensing agreement…

Read More
Pharmaceutical R&D

Pfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership

Teuku Ryan Oct 14, 2026 0

Pharmaceutical giant Pfizer has entered into a strategic research collaboration and licensing agreement with Enodia Therapeutics valued at upwards of…

Read More
Pharmaceutical R&D

Eli Lilly Expands Multi-Million Dollar Biotech Partnership with Gate Bioscience to Pioneer ‘Molecular Gate’ Therapies for Hard-to-Drug Proteins

Teuku Ryan Oct 7, 2026 0

Eli Lilly and Company has significantly deepened its footprint in cutting-edge drug discovery by expanding its strategic partnership and licensing…

Read More
Pharmaceutical R&D

MSD Strengthens Oncology Pipeline with Multi-Billion-Dollar Licensing Deal for Shanghai-Based SciBrunch Therapeutics KRAS Inhibitor SPR2015

Teuku Ryan Sep 30, 2026 0

In a strategic move to fortify its oncology portfolio against looming patent expirations, MSD—known as Merck & Co. in the…

Read More
Pharmaceutical R&D

Roche Deepens AI and Small Molecule Strategy with Multi-Billion-Dollar Partnerships in Oncology and CVRM

Teuku Ryan Sep 26, 2026 0

Swiss pharmaceutical giant Roche, acting through its subsidiary Genentech, has entered a blockbuster agreement with Earendil Labs, committing up to…

Read More
Pharmaceutical R&D

Roche and Dualitas Therapeutics Ink Billion-Dollar Partnership to Advance Next-Generation Bispecific Antibodies in Immunology and Inflammation

Teuku Ryan Sep 19, 2026 0

In a landmark agreement that underscores the surging therapeutic potential of proximity biology, Swiss pharmaceutical giant Roche has joined forces…

Read More
Pharmaceutical R&D

Biopharma M&A Surges as Billion-Dollar Deals Fuel Pipeline Replenishment Amidst Patent Cliff Pressures

Teuku Ryan Jun 18, 2026 0

The biopharmaceutical industry is experiencing a significant resurgence in merger and acquisition (M&A) activity, driven by a wave of high-value…

Read More
Laboratory Automation & Robotics

A Billion-Dollar Telehealth Empire Built on Regulatory Cracks: The Medvi Controversy

Lana Keisha Apr 24, 2026 0

Medvi, a telehealth company recently profiled by The New York Times as an AI-powered success story, is projected by its…

Read More
Arna Pharma and Slate Run Pharmaceuticals Forge Strategic Joint Venture to Accelerate Pharmaceutical Product Commercialization in the US MarketEli Lilly and Profluent Partner to Harness AI for Advanced Recombinase-Based Gene EditingINTEGRA Biosciences Automates Quantabio sparQ DNA Frag & Library Prep Kit Workflow, Enhancing NGS Efficiency and ReproducibilityThe latent threat of rival groups may select for larger males, even without frequent fights
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ